Login to MyKarger

New to MyKarger? Click here to sign up.

Login with Facebook

Forgot Password? Reset your password

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login (Shibboleth)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Table of Contents
Vol. 219, No. 4, 2009
Issue release date: November 2009
Section title: Letter to Dermatology
Free Access
Dermatology 2009;219:357–358

Bullous Pemphigoid during Long-Term TNF-α Blocker Therapy

Bordignon M.a · Belloni-Fortina A.a · Pigozzi B.b · Tarantello M.a · Alaibac M.a
aUnit of Dermatology, University of Padua, and bVeneto Institute of Oncology, IRCCS, Padua, Italy
email Corresponding Author

Mauro Alaibac, MD, PhD

Via Cesare Battisti 206

IT–35128 Padova (Italy)

Tel. +39 049 821 2901, Fax +39 049 821 8891

E-Mail mauro.alaibac@unipd.it

Do you have an account?

Login Information

Contact Information

I have read the Karger Terms and Conditions and agree.

First-Page Preview
Abstract of Letter to Dermatology

Article / Publication Details

Published online: October 01, 2009
Issue release date: November 2009

Number of Print Pages: 2
Number of Figures: 0
Number of Tables: 0

ISSN: 1018-8665 (Print)
eISSN: 1421-9832 (Online)

For additional information: http://www.karger.com/DRM

Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.